Market Cap 53.23M
Revenue (ttm) 22.36M
Net Income (ttm) -41.71M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -186.54%
Debt to Equity Ratio 0.50
Volume 60,900
Avg Vol 9,642
Day's Range N/A - N/A
Shares Out 7.31M
Stochastic %K 67%
Beta 1.09
Analysts Sell
Price Target $10.50

Company Profile

DarioHealth Corp. operates as a digital health company in the United States and internationally. Its digital therapeutics platform and suite of solutions deliver personalized and dynamic interventions driven by data analytics and one-on-one coaching for diabetes, hypertension, weight management, musculoskeletal pain, and behavioral health. The company offers Dario Connect, a solution used to create communities around specific health conditions to increase awareness and education; Dario Mind, a b...

Industry: Health Information Services
Sector: Healthcare
Address:
322 W. 57th Street, New York, United States
Mrtgrich3
Mrtgrich3 Jul. 4 at 12:32 PM
$DRIO Ownership and Share Information1 DarioHealth Corp. has a market cap of US$51.41 million, with 7.3 million shares outstanding. The company's 52-week range is US$5.84-US$17.74. Institutions own 39.4% of shares, while Strategic Investors own 7.5%. Management & Insiders own 4.5% of shares, and the remaining 48.6% of shares are held by Retail.
0 · Reply
ConnectionIsLife
ConnectionIsLife Jul. 3 at 5:44 PM
$DRIO Very informative piece. If their business model is improving the margins per beneficiary for health plans and employers (which is the single biggest threat to the market, and no one can tackle it)...bingo. Two key passages: 1. The agreement with Beluga positions DarioHealth as a quality and revenue performance partner for health plans that delivers impact based on where plans are economically incentivized, the release noted. Notably, even a minor improvement in CMS Star Ratings, such as a half-star gain, could translate to approximately $500 per member, while addressing gaps in risk-adjustment documentation could save over $1,000 per member annually. 2. (O'Reilly's) expertise in utilizing advanced data analytics and AI to enhance compliance and operational performance is particularly relevant to DarioHealth's focus on delivering measurable health outcomes through innovative technological solutions.
1 · Reply
StreetwiseReports
StreetwiseReports Jul. 2 at 11:25 PM
Digital Health Pioneer Targets Massive Breakthrough Chronic Care Market https://ow.ly/yAon50ZjSZH AI-driven digital health solutions pioneer DarioHealth Corp. ( $DRIO ) announces a partnership that it says will give it access to a network spanning all 50 states. Find out why analysts like the direction the company is taking. @dario_health
0 · Reply
Torn891
Torn891 Jul. 2 at 4:56 PM
$DRIO Firing up the paid PR machine again. Here comes another insufferable set of financial results for q2.
0 · Reply
dario_health
dario_health Jul. 2 at 4:24 PM
Streetwise Reports just highlighted DarioHealth’s new collaboration with Beluga Health, combining Dario’s multi-condition platform with a physician-led network that spans all 50 states. The model is built to connect monitoring, detection, and treatment across hypertension, diabetes, obesity, behavioral health, and musculoskeletal care in one platform. The article also points to published outcomes showing 23% lower hospitalization rates and 26% lower total charges, alongside analyst coverage citing a growing commercial pipeline and Buy/Outperform targets of $25 and $28. $DRIO #DigitalHealth #ChronicCare #AIHealthcare https://api.stocktwits.com/widgets/share
0 · Reply
prismmarketview
prismmarketview Jul. 2 at 4:11 PM
PRISM Mid-Day Movers: Weight Loss and Biotech are Today’s Leaders. Allurion Technologies Inc. (OTC: $ALUR) is ripping higher again today, with the stock up about 36%to 4.00 from a prior close of 2.94. Chemomab Therapeutics Ltd. (NASDAQ: $CMMB ) is having a strong session, with the stock up about 32% to 2.2401 from a prior close of 1.70. Other Notable Movers: DarioHealth Corp. ($DRIO ) up 13% LifeMD inc. ( $LFMD ) up 10% Aspira Women’s Health ( $AWH) down -15% https://prismmarketview.com/prism-mid-day-movers-weight-loss-and-biotech-are-todays-leaders-2/
0 · Reply
Bilbaggin
Bilbaggin Jul. 2 at 3:47 PM
$DRIO I smell something
0 · Reply
NJgolfer
NJgolfer Jul. 2 at 3:13 PM
$DRIO wealth destroyer - down 12% over the last 3 months and down 6% in the last month. Don't trust these guys with your investment capital
0 · Reply
OpenOutcrier
OpenOutcrier Jul. 2 at 12:50 PM
$DRIO (+6.1% pre) One of the U.S.'s biggest insurers expands Dario into hypertension https://ooc.bz/l/106751
0 · Reply
DCA1120
DCA1120 Jul. 2 at 11:38 AM
$DRIO https://www.prnewswire.com/news-releases/top-national-health-plan-extends-agreement-for-mental-health-and-expands-dario-partnership-into-cardiometabolic-care-demonstrating-successful-multi-condition-growth-strategy-302816343.html
1 · Reply
Latest News on DRIO
DarioHealth Earnings Call Transcript: Q1 2026

May 13, 2026, 8:30 AM EDT - 7 weeks ago

DarioHealth Earnings Call Transcript: Q1 2026


DarioHealth Quarterly report: Q1 2026

May 13, 2026, 8:30 AM EDT - 7 weeks ago

DarioHealth Quarterly report: Q1 2026


DarioHealth Earnings release: Q1 2026

May 13, 2026, 8:30 AM EDT - 7 weeks ago

DarioHealth Earnings release: Q1 2026


DarioHealth Slides: Q1 2026

May 13, 2026, 8:30 AM EDT - 7 weeks ago

DarioHealth Slides: Q1 2026


DarioHealth reports Q1 EPS ($1.25), consensus (85c)

2026-05-13T11:51:14.000Z - 7 weeks ago

DarioHealth reports Q1 EPS ($1.25), consensus (85c)


DarioHealth Slides: Corporate presentation

Apr 15, 2026, 7:00 AM EDT - 2 months ago

DarioHealth Slides: Corporate presentation


DarioHealth Slides: Corporate presentation

Apr 10, 2026, 7:00 AM EDT - 3 months ago

DarioHealth Slides: Corporate presentation


DarioHealth trading resumes

2026-04-08T17:00:51.000Z - 3 months ago

DarioHealth trading resumes


DarioHealth trading halted, volatility trading pause

2026-04-08T16:55:48.000Z - 3 months ago

DarioHealth trading halted, volatility trading pause


DarioHealth price target lowered to $10 from $16 at Stifel

2026-03-20T11:45:54.000Z - 3 months ago

DarioHealth price target lowered to $10 from $16 at Stifel


DarioHealth files $100M mixed securities shelf

2026-03-19T21:05:39.000Z - 3 months ago

DarioHealth files $100M mixed securities shelf


DarioHealth Earnings Call Transcript: Q4 2025

Mar 19, 2026, 8:30 AM EDT - 3 months ago

DarioHealth Earnings Call Transcript: Q4 2025


DarioHealth Earnings release: Q4 2025

Mar 19, 2026, 8:30 AM EDT - 3 months ago

DarioHealth Earnings release: Q4 2025


DarioHealth Annual report: Q4 2025

Mar 19, 2026, 8:30 AM EDT - 3 months ago

DarioHealth Annual report: Q4 2025


DarioHealth Registration statement: Registration filing

Mar 19, 2026, 8:00 AM EDT - 3 months ago

DarioHealth Registration statement: Registration filing


DarioHealth reports  Q4 revenue $5.2M, consensus $5.05M

2026-03-19T10:41:17.000Z - 3 months ago

DarioHealth reports Q4 revenue $5.2M, consensus $5.05M


DarioHealth Registration statement: Registration Filing

Dec 29, 2025, 7:00 AM EST - 6 months ago

DarioHealth Registration statement: Registration Filing


DarioHealth Proxy statement: Proxy Filing

Dec 22, 2025, 7:00 AM EST - 6 months ago

DarioHealth Proxy statement: Proxy Filing


DarioHealth Proxy statement: Proxy Filing

Dec 11, 2025, 7:00 AM EST - 7 months ago

DarioHealth Proxy statement: Proxy Filing


DarioHealth announces 79 new accounts signed year-to-date

2025-12-02T13:05:34.000Z - 7 months ago

DarioHealth announces 79 new accounts signed year-to-date


DarioHealth price target raised to $11 from 60c at TD Cowen

2025-11-14T13:50:25.000Z - 8 months ago

DarioHealth price target raised to $11 from 60c at TD Cowen


DarioHealth Earnings Call Transcript: Q3 2025

Nov 13, 2025, 8:30 AM EST - 8 months ago

DarioHealth Earnings Call Transcript: Q3 2025


DarioHealth Earnings release: Q3 2025

Nov 13, 2025, 8:30 AM EST - 8 months ago

DarioHealth Earnings release: Q3 2025


DarioHealth Quarterly report: Q3 2025

Nov 13, 2025, 8:30 AM EST - 8 months ago

DarioHealth Quarterly report: Q3 2025


DarioHealth Slides: Corporate Presentation

Nov 13, 2025, 7:00 AM EST - 8 months ago

DarioHealth Slides: Corporate Presentation


DarioHealth reports Q3 EPS ($2.96), consensus ($2.42)

2025-11-13T11:41:04.000Z - 8 months ago

DarioHealth reports Q3 EPS ($2.96), consensus ($2.42)


DarioHealth Registration statement: Registration Filing

Oct 20, 2025, 8:00 AM EDT - 9 months ago

DarioHealth Registration statement: Registration Filing


DarioHealth signs six new employer clients to portfolio

2025-10-13T12:40:47.000Z - 9 months ago

DarioHealth signs six new employer clients to portfolio


DarioHealth, OneStep announce strategic collaboration

2025-10-06T11:36:27.000Z - 9 months ago

DarioHealth, OneStep announce strategic collaboration


DarioHealth Announces 20-to-1 Reverse Stock Split

Aug 25, 2025, 8:00 AM EDT - 11 months ago

DarioHealth Announces 20-to-1 Reverse Stock Split


DarioHealth Earnings Call Transcript: Q2 2025

Aug 12, 2025, 8:30 AM EDT - 11 months ago

DarioHealth Earnings Call Transcript: Q2 2025


DarioHealth Earnings release: Q2 2025

Aug 12, 2025, 8:30 AM EDT - 11 months ago

DarioHealth Earnings release: Q2 2025


DarioHealth Quarterly report: Q2 2025

Aug 12, 2025, 8:30 AM EDT - 11 months ago

DarioHealth Quarterly report: Q2 2025


DarioHealth Slides: Corporate Presentation

Aug 12, 2025, 7:00 AM EDT - 11 months ago

DarioHealth Slides: Corporate Presentation


DarioHealth Registration statement: Registration Filing

Jul 31, 2025, 8:00 AM EDT - 1 year ago

DarioHealth Registration statement: Registration Filing


DarioHealth Proxy statement: Proxy Filing

May 30, 2025, 8:00 AM EDT - 1 year ago

DarioHealth Proxy statement: Proxy Filing


DarioHealth Registration statement: Registration Filing

May 28, 2025, 8:00 AM EDT - 1 year ago

DarioHealth Registration statement: Registration Filing


DarioHealth Proxy statement: Proxy Filing

May 20, 2025, 8:00 AM EDT - 1 year ago

DarioHealth Proxy statement: Proxy Filing


DarioHealth Earnings Call Transcript: Q1 2025

May 14, 2025, 8:30 AM EDT - 1 year ago

DarioHealth Earnings Call Transcript: Q1 2025


DarioHealth Earnings release: Q1 2025

May 14, 2025, 8:30 AM EDT - 1 year ago

DarioHealth Earnings release: Q1 2025


DarioHealth Quarterly report: Q1 2025

May 14, 2025, 8:30 AM EDT - 1 year ago

DarioHealth Quarterly report: Q1 2025


DarioHealth Slides: Corporate Presentation

May 14, 2025, 7:00 AM EDT - 1 year ago

DarioHealth Slides: Corporate Presentation


DarioHealth Announces CFO Transition

Apr 21, 2025, 8:30 AM EDT - 1 year ago

DarioHealth Announces CFO Transition

BNRG


/C O R R E C T I O N -- DarioHealth Corp./

Mar 17, 2025, 8:30 AM EDT - 1 year ago

/C O R R E C T I O N -- DarioHealth Corp./


DarioHealth Earnings Call Transcript: Q4 2024

Mar 10, 2025, 8:30 AM EDT - 1 year ago

DarioHealth Earnings Call Transcript: Q4 2024


DarioHealth Earnings release: Q4 2024

Mar 10, 2025, 8:30 AM EDT - 1 year ago

DarioHealth Earnings release: Q4 2024


DarioHealth Annual report: Q4 2024

Mar 10, 2025, 8:30 AM EDT - 1 year ago

DarioHealth Annual report: Q4 2024


DarioHealth Slides: Corporate Presentation

Mar 10, 2025, 8:00 AM EDT - 1 year ago

DarioHealth Slides: Corporate Presentation


DarioHealth Proxy statement: Proxy Filing

Mar 10, 2025, 8:00 AM EDT - 1 year ago

DarioHealth Proxy statement: Proxy Filing


DarioHealth Proxy statement: Proxy Filing

Feb 28, 2025, 7:00 AM EST - 1 year ago

DarioHealth Proxy statement: Proxy Filing


Mrtgrich3
Mrtgrich3 Jul. 4 at 12:32 PM
$DRIO Ownership and Share Information1 DarioHealth Corp. has a market cap of US$51.41 million, with 7.3 million shares outstanding. The company's 52-week range is US$5.84-US$17.74. Institutions own 39.4% of shares, while Strategic Investors own 7.5%. Management & Insiders own 4.5% of shares, and the remaining 48.6% of shares are held by Retail.
0 · Reply
ConnectionIsLife
ConnectionIsLife Jul. 3 at 5:44 PM
$DRIO Very informative piece. If their business model is improving the margins per beneficiary for health plans and employers (which is the single biggest threat to the market, and no one can tackle it)...bingo. Two key passages: 1. The agreement with Beluga positions DarioHealth as a quality and revenue performance partner for health plans that delivers impact based on where plans are economically incentivized, the release noted. Notably, even a minor improvement in CMS Star Ratings, such as a half-star gain, could translate to approximately $500 per member, while addressing gaps in risk-adjustment documentation could save over $1,000 per member annually. 2. (O'Reilly's) expertise in utilizing advanced data analytics and AI to enhance compliance and operational performance is particularly relevant to DarioHealth's focus on delivering measurable health outcomes through innovative technological solutions.
1 · Reply
StreetwiseReports
StreetwiseReports Jul. 2 at 11:25 PM
Digital Health Pioneer Targets Massive Breakthrough Chronic Care Market https://ow.ly/yAon50ZjSZH AI-driven digital health solutions pioneer DarioHealth Corp. ( $DRIO ) announces a partnership that it says will give it access to a network spanning all 50 states. Find out why analysts like the direction the company is taking. @dario_health
0 · Reply
Torn891
Torn891 Jul. 2 at 4:56 PM
$DRIO Firing up the paid PR machine again. Here comes another insufferable set of financial results for q2.
0 · Reply
dario_health
dario_health Jul. 2 at 4:24 PM
Streetwise Reports just highlighted DarioHealth’s new collaboration with Beluga Health, combining Dario’s multi-condition platform with a physician-led network that spans all 50 states. The model is built to connect monitoring, detection, and treatment across hypertension, diabetes, obesity, behavioral health, and musculoskeletal care in one platform. The article also points to published outcomes showing 23% lower hospitalization rates and 26% lower total charges, alongside analyst coverage citing a growing commercial pipeline and Buy/Outperform targets of $25 and $28. $DRIO #DigitalHealth #ChronicCare #AIHealthcare https://api.stocktwits.com/widgets/share
0 · Reply
prismmarketview
prismmarketview Jul. 2 at 4:11 PM
PRISM Mid-Day Movers: Weight Loss and Biotech are Today’s Leaders. Allurion Technologies Inc. (OTC: $ALUR) is ripping higher again today, with the stock up about 36%to 4.00 from a prior close of 2.94. Chemomab Therapeutics Ltd. (NASDAQ: $CMMB ) is having a strong session, with the stock up about 32% to 2.2401 from a prior close of 1.70. Other Notable Movers: DarioHealth Corp. ($DRIO ) up 13% LifeMD inc. ( $LFMD ) up 10% Aspira Women’s Health ( $AWH) down -15% https://prismmarketview.com/prism-mid-day-movers-weight-loss-and-biotech-are-todays-leaders-2/
0 · Reply
Bilbaggin
Bilbaggin Jul. 2 at 3:47 PM
$DRIO I smell something
0 · Reply
NJgolfer
NJgolfer Jul. 2 at 3:13 PM
$DRIO wealth destroyer - down 12% over the last 3 months and down 6% in the last month. Don't trust these guys with your investment capital
0 · Reply
OpenOutcrier
OpenOutcrier Jul. 2 at 12:50 PM
$DRIO (+6.1% pre) One of the U.S.'s biggest insurers expands Dario into hypertension https://ooc.bz/l/106751
0 · Reply
DCA1120
DCA1120 Jul. 2 at 11:38 AM
$DRIO https://www.prnewswire.com/news-releases/top-national-health-plan-extends-agreement-for-mental-health-and-expands-dario-partnership-into-cardiometabolic-care-demonstrating-successful-multi-condition-growth-strategy-302816343.html
1 · Reply
ConnectionIsLife
ConnectionIsLife Jul. 1 at 3:17 PM
$DRIO This is great. Your point would explain a few things - for instance, why every positive news day sees two things: 1) the same shorts casting doubts: and 2) heavier volume pre-market and opening to drive the price down. As for the board....their business is literally changing how care is delivered and by what workforce. The entry into the market for that is insurance companies. And they have a plugged in guy who can help translate what the payers need to see for that to land. Thank you for the unique perspective and insight...happy 4th
0 · Reply
Ravery
Ravery Jun. 30 at 5:44 PM
$DRIO Agreed that Sean O'Reilly is an impressive add for a small company like Dario. That being said, being on the advisory board doesn't always mean that much. Some board members become actively involved and other more or less just take the free shares and add little value. According to his linkedin page, he has various position at humana for 13 years and now a senior managing director at FTI consulting. Impressive. He does not list any board positions. So if he did join Dario as his only board position, that is an eyebrow raiser. Interesting nonetheless.
0 · Reply
TheBearVsTheBull
TheBearVsTheBull Jun. 30 at 5:09 PM
$DRIO $DRIO To all the share holders, do any of you have an idea how much of the total shares outstanding is being privately held, not just to dilute, but in hopes for Perella Weinberg to be able to sell the company. The companies portfolio just got substantially stronger and Sean O’Reilly is a monster add to the board and is renown in his industry. Why doesn’t this reflect in stock price you may ask? Well pretty simple. With barely any circulating supply, YOU MAY HAVE TO PAY A HIGHER PRICE WHICH WILL RUN THE STOCK…. I just hope it doesn’t run away from you trying to be greedy.
0 · Reply
DueDilly102
DueDilly102 Jun. 30 at 12:45 PM
$DRIO 'advisory board'....how many shares did it cost us?
0 · Reply
focafoca99
focafoca99 Jun. 30 at 11:45 AM
$DRIO joined former Humana compliance chief Sean O'Reilly on its advisory board to support strategic growth.
0 · Reply
TheBearVsTheBull
TheBearVsTheBull Jun. 29 at 11:45 AM
$DRIO https://dariohealth.investorroom.com/2026-06-29-Dario-Announces-Strategic-Collaboration-with-Beluga-Health-to-Deliver-Provider-Backed,-Integrated-Care-at-Scale This is HUGE for the company
1 · Reply
printcomm
printcomm Jun. 26 at 5:04 PM
$DRIO Streetwise....Important Disclosures: Dario Health is a billboard sponsor of Streetwise Reports and pays SWR a monthly sponsorship fee between US$3,000 and US$6,000.
0 · Reply
StreetwiseReports
StreetwiseReports Jun. 25 at 4:03 PM
DarioHealth: Chronic Care Platform Drives Value https://ow.ly/njCn50ZheVu DarioHealth targets the booming digital health market with a multi-condition platform backed by 27 ADA studies. See pipeline growth, analyst targets, and key catalysts for investors. $DRIO
0 · Reply
dario_health
dario_health Jun. 24 at 9:00 PM
0 · Reply
StreetwiseReports
StreetwiseReports Jun. 24 at 8:57 PM
Four New ADA Studies Reveal Clinical Wins in Weight, Blood Sugar, and Healthcare Utilization https://ow.ly/N7q250ZgrX7 DarioHealth Corp. ( $DRIO ) presented four studies at the ADA Scientific Sessions reporting weight loss of up to 14.3%, fewer hospitalizations, and improved glycemic outcomes among high-risk cardiometabolic users of its digital health platform. @dario_health
0 · Reply
Ravery
Ravery Jun. 22 at 8:40 PM
$DRIO One advantage here is if anyone was interested in adding to their position, this stock consistently gives you opportunities to lower your cost basis. 😆 Unfortunate that C-suite doesn't seize the opportunity as the price is getting close to all time lows again. Steve bought in the first half of 2025, but nothing since. Oh well
0 · Reply
CalciumNitrate
CalciumNitrate Jun. 22 at 2:34 PM
$DRIO sigh
0 · Reply